Mouse resident peritoneal macrophages incubated with ionophore A23187 or opsonized zymosan released leukotrienes (LT) B4 and C4 (LTB4 and LTC4) and LTC4 and LTD4, respectively. In contrast, incubation with Toxoplasma gondii, an obligate intracellular protozoan, led to the formation of 11-, 12-, and 15-hydroxyicosatetraenoic acids (HETEs), together with an unidentified compound, designated compound X. Each of these compounds incorporated [3H]arachidonic acid from the macrophage during phagocytosis of T. gondi. Compound X migrated immediately prior to 15-HETE by reversephase HPLC and was distinct from authentic monoHETE, monohydroperoxyicosatetraenoic acid (mono-HPETE), and dihydroxyicosatetraenoic acid (diHETE) standards. The generation of compound X by macrophages correlated with the extent of phagocytosis of T. gondii and with intracellular survival of the organisms. Prior antibody-coating of T. gondii or activation of macrophages, either of which inhibited survival and replication of ingested organisms, was associated with production of LTD4 but not compound X. Killed organisms also stimulated LTD4 release only. Although T. gondii concentrated arachidonic acid, they did not metabolize the compound to identifiable lipoxygenase products. Preincubation of macrophages with the relative lipoxygenase inhibitors nordihydroguaiaretic acid or 5,8,11,14-icosatetraynoic acid inhibited the formation of compound X. The absence of leukotriene production by macrophages ingesting T. gondji may explain the relative lack of a neutrophil inflammatory response in diseases due to obligate intracellular organisms. Alternatively, compound X may have functional activities that might mediate some of the host responses to cellular parasitism.
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The leukotrienes (LT) have been identified as potentially important inflammatory mediators of host defense (1, 2) . LTB4 is a potent neutrophil chemoattractant and stimulus for aggregation, degranulation, and adherence to endothelium. The sulfidopeptide leukotrienes LTC4, LTD4, and LTE4, which collectively constitute the slow-reacting substance of anaphylaxis (SRS), promote vasoconstriction and enhance permeability across the postcapillary venule. Resident tissue macrophages are major sources of the LT (3) (4) (5) . The plasma membrane of these cells is rich in esterified arachidonate that is released during membrane perturbation and is then available to Ca2+-dependent 5-lipoxygenase that regulates the formation of the LT (6, 7) . Traditional stimuli for LT production by macrophages in vitro include both soluble (calcium ionophore A23187, endotoxin, phorbol myristate acetate) and particulate (zymosan, immunocomplexes) stimuli; LT production in response to the latter has been related directly to the degree of phagocytosis (3) (4) (5) .
Resident tissue macrophages are the initial target of many obligate intracellular pathogens that infect man, but the capacity of viable organisms to trigger the release of inflammatory mediators from macrophages has not been systematically investigated. The pathogenic protozoa are particularly adept at survival within macrophages (8) . Because a significant neutrophilic response is infrequent in such infections, we examined the ability of macrophages to generate LT while ingesting the obligate intracellular protozoan Toxoplasma gondii. Murine Peritoneal Macrophages. Resident peritoneal cells were collected in Ca2+/Mg2+-free Hanks' balanced salt solution (GIBCO) by lavage of 5-to 8-week-old BALB/c or C57BL/6 mice as described (9) . Corynebacterium parvumactivated peritoneal macrophages were collected similarly from animals that had been given 1.4 mg of C. parvum suspension (Wellcome) intraperitoneally 12 days previously. Macrophage monolayers were established by adherence followed by washing in 35-mm tissue culture dishes as described (9) . The addition of 6 x 106 macrophages per dish yielded z300 ,ug ofadherent protein when using resident cells and -400 ug of adherent protein when using C. parvumactivated cells. The monolayers, composed of 98% nonspecific esterase-positive cells, were incubated overnight for 18 hr. In selected experiments, 1 tCi/ml of [3H]arachidonic acid (AA; specific activity, 62.2 Ci/mmol; New England Nuclear; 1 Ci = 37 GBq) was added to the overnight cultures.
MATERIALS AND METHODS
T. gondi. T. gondii RH strain was maintained by intraperitoneal passage in BALB/c mice. The organisms were harvested by peritoneal lavage, separated from leukocytes by filtration through a 3-,um polycarbonate filter (Nuclepore), washed three times, and suspended at 107 T. gondii per ml in Krebs-Ringer phosphate buffer (pH 7.4) containing 5.5 mM glucose (KRPG buffer) as described (9) . Organisms prepared in this fashion were >90% viable as assessed by acridine orange-ethidium bromide fluorescence (9) . In selected studies, T. gondii were heat-killed by incubation at 100°C (Sigma) . After allowing the mixture to settle and then shaking them for 60 min at 37°C, supernatants were harvested into iced tubes and cleared by centrifugation. Superoxide dismutase-inhibitable ferricytochrome c reduction was used to calculate superoxide anion (O2 ) generation (9) , and the oxidation of scopoletin was used to calculate H202 production as described (10) .
Phagocytosis. Macrophage monolayers were established on 15-mm glass coverslips as described (9) and challenged with zymosan or T. gondii at the same concentrations used for the generation of LT. At the indicated time points, coverslips were washed to remove nonadherent particles, fixed in 2.5% glutaraldehyde, and stained with Dif-Quik. The number of ingested particles per cell was assessed microscopically under oil immersion. Intracellular survival and replication of T. gondii were determined by light microscopy from coverslips examined 20 hr after infection of monolayers using a ratio of 2 or 3 T. gondii per macrophage as described (9) .
Phagolysosomal Fusion. Macrophage monolayers on glass coverslips were incubated at 37°C in Hanks' balanced salt solution containing 20 ,g of acridine orange per ml, washed, and reincubated in RPMI medium for 1 hr before challenge with zymosan or T. gondii. After 30 min, coverslips were washed and inverted onto a drop of glycerol on a microscope slide. The percentage of ingested particles promoting phagolysosomal fusion was quantitated by using fluorescence microscopy as described (11) .
Assay for Lipoxygenase Products of Arachidonate. Supernatants underwent solid-phase extraction using 3-ml octadecyl Baker-10 columns (J. T. Baker Chemical, Phillipsburg, NJ) as described (12) . Eluants were evaporated to dryness under nitrogen, suspended in methanol/water/acetic acid, 75:25:0.01 (vol/vol), pH 7.4, clarified by centrifugation (3000 x g for 5 min at 4°C), and applied to a 5-,um Ultrasphere ODS C18 column (4.6 x 250 mm; Beckman Instruments, Berkeley, CA). Reverse-phase HPLC (RP-HPLC) was subsequently performed with the same solvent at a flow rate of 1 ml/min. Substances eluted in peaks at 280 nm and 235 nm were rechromatographed by RP-HPLC on a 3-,um particle size Beckman Ultrasphere ODS C18 column (4.6 x 75 mm) with the same solvent at a flow rate of 1.6 ml/min and by straight-phase HPLC (SP-HPLC) on a ,uPorasil column (3.9
x 300 mm; Waters Associates) with hexane/isopropanol, 100:0.45 (vol/vol), at a flow rate of 1 ml/min. Peaks were identified by coelution with authentic standards, UV spectroscopy, and biologic activity as described (13) . The amount of each compound was determined by using the extinction coefficient of the identified arachidonate product. The radioactivity of eluted peak material was measured by a FLO-ONE model HP radioactive flow detector (Radiomatic, Tampa, FL) using Radiomatic FLO-SCINT II at a scintillant/HPLC solvent ratio of 2:1. The slow-reacting substance of anaphylaxis activity of the sulfidopeptide leukotrienes was determined by the guinea pig ileal bioassay, and chemotactic activity of peak material that rechromatographed with LTB4 was measured by the leading-front assay with human neutrophils as described (14) .
Uptake of AA and AA-Derived Products by T. gondii. RESULTS Resident BALB/c peritoneal macrophages were challenged with either the calcium ionophore A23187 or opsonized zymosan and were incubated for 20 min or 90 min, respectively; supernatants from this treatment were analyzed by HPLC (Fig. 1 ). LT were identified by their comigration in RPand SP-HPLC with authentic standards, their characteristic UV spectra, and their biologic activity (chemotactic activity for LTB4 and slow-reacting substance of anaphylaxis activity for LTC4 and LTD4). After A23187 challenge (Fig. 1A) , macrophages released LTC4 (1.3 ,ug/mg of monolayer protein) and LTB4 (0.3 ,ug/mg). After ingestion of zymosan (Fig.  1B) , LTD4 (0.6 ,ug/mg) was the major product released. However, challenge with viable T. gondii (Fig. 1C) ,ug/mg) were also recovered, as assessed by coelution with rechromatographed HETE standards and characteristic UV spectra. When T. gondii were killed by heating prior to incubation with resident macrophages, the major product recovered was LTD4 (0.7 ,.g/mg) (Fig. 1D) . Glutaraldehydefixed T. gondii gave an elution chromatogram identical to that of heat-killed T. gondii. Compound X and the monoHETEs were not present. Macrophages from C57BL/6 mice produced comparable findings for each of the stimuli. Incubation of macrophages alone under these conditions resulted in no detectable release of lipoxygenase products.
Although ingestion of heat-killed T. gondii was not accompanied by the alteration in lipoxygenase products that occurred during phagocytosis of viable T. gondii ( Fig. 1 C and  D) , this was not due to impaired phagocytosis of heat-killed organisms. Phagocytosis of viable and heat-killed organisms was comparable under these conditions (Fig. 2) burst of the phagocyte (15) and impede the fusion of potentially toxic lysosomes with the phagosome (16) . As previously reported (9, 15, 17) , resident macrophages produced little O°2 or H202 after ingestion of T. gondii, and only 12% of ingested organisms showed evidence of phagolysosomal fusion (Table 1) . T. gondii readily replicated in these cells, with 4.9 organisms per vacuole 20 hr after infection. In contrast, opsonized zymosan was a potent inducer both of the respiratory burst and of phagolysosomal fusion. The respiratory burst provoked by heat-killed T. gondii was poor, although ingested organisms did demonstrate phagolysosomal fusion.
Prior incubation of T. gondii with specific antibody is nontoxic in the absence of complement but renders the organisms susceptible to the microbicidal systems of resident macrophages (18) . Antibody-coated T. gondii induced a readily detectable respiratory burst and did not impede phagolysosomal fusion during ingestion by resident macrophages (Table 1 ). More than 75% of ingested organisms were killed, and T. gondii surviving at 20 hr replicated poorly (1.3 ± 0.2 Toxoplasma per vacuole). Supernatants from macrophages ingesting antibody-coated T. gondii contained LTD4 but no monoHETEs or compound X (data not shown).
Activation of macrophages also enables these cells to kill T. gondii (19 Resident nmacrophages were incubated with inhibitors of AA metabolism before and during phagocytosis of viable T. gondii; then the supernatants were extracted and analyzed by HPLC to determine effects on the formation of compound X. As assessed by the height of peak X absorbance, the generation of compound X was significantly less in the presence of the relative lipoxygenase inhibitors 5,8,11,14-icosatetraynoic acid and nordihydroguariaretic acid at concentrations of both 100 ,uM (2.5 ± 5.4% and 4.9 ± 4.3% of control, respectively) and 10 ,uM (7.4 ± 2.4% and 12.2+ 6.0%, respectively). The relative cyclooxyg'enase inhibitor indomethacin had little effect on the formation of compound X (97.6 ± 0.1% of control at 100 ,uM). Resident *Assessed by superoxide dismutase-inhibitable ferricytochrome c reduction at 60 min. Responses to phorbol 12-myristate 13-acetate at 100 ng/ml were 110 and 376 nmol of 02j per mg of protein per 60 min for resident and C. parvum-activated macrophages, respectively. Results shown are means ± SEM (n = 3-7).
tAssessed by fluorescence quenching of scopoletin at 60 min. Responses to phorbol 12-myristate 13-acetate at 100 ng/ml were 80 and 465 nmol of H202 per mg of protein per 60 mn for resident and C. parvum-activated macrophages, respectively. Results shown are means ± SEM (n = 3).
tPercentage of ingested particles showing diffuse orange fluorescence. Results are means ± SEM of duplicate determinations (n = 2-3).
ration of the radiolabeled precursor (Fig. 4A) . Conversely, T. gondii were preincubated with [3H]AA for 30 min, washed extensively, and used to challenge unlabeled resident macrophages. The supernatants were analyzed by RP-HPLC, and the collected fractions were assayed for radioactivity (Fig. 4B) . As with unlabeled organisms, compound X and the monoHETEs were recovered. However, whereas 11-, 12-, and 15-HETE were radiolabeled, compound X was not.
DISCUSSION
These studies demonstrate that resident murine macrophages release a novel profile of lipoxygenase products when phagocytizing the obligate intracellular protozoan T. could be recovered in the supernatant within 30 min of incubation of macrophages with T. gondii, and peak levels were obtained between 90 and 120 min, a process that correlated with the ingestion of organisms as assessed microscopically (Fig. 2) . Second, organisms had to be viable. Boiling or fixing T. gondii in glutaraldehyde prior to incubation with resident macrophages provoked subsequent LT release that was comparable to that released by ingestion of zymosan. Third, organisms had to survive and replicate intracellularly after phagocytosis. Prior antibody-coating of T. gondii, which enables resident macrophages to kill these protozoa (18) , did not provoke a lipoxygenase shift in resident macrophages. Further, C. parvum-activated macrophages, which significantly impaired both T. gondii survival and replication, also did not generate compound X during phagocytosis of viable T. gondii.
Although viable T. gondii were required to generate the unique profile of lipoxygenase products recovered, there was no evidence that the organisms themselves produced compound X, either directly or from substances released from zymosan-triggered macrophages. T. gondii readily incorporated AA but formed no detectable oxidation products either spontaneously or after ionophore stimulation. T. gondii presumably share with other intracellular protozoa the capacity to utilize free fatty acids as an energy source via two-carbon 1-oxidation (20, 21 (Fig. 4B) was an unexpected finding. Although macrophage utilization of exogenous AA supplied by lymphocytes has been reported (22) , the capacity of these cells to utilize AA supplied by an ingested microorganism has not been described to our knowledge.
The mechanism by which viable T. gondii induce a shift in macrophage AA metabolism is unknown. Lipoxygenase pathways in macrophages are not constitutive, but are presumably activated by the Ca2l fluxes accompanying membrane perturbation (23, 24) . Generation of compound X and the monoHETEs correlated directly with the extent of phagocytosis of viable T. gondii. These organisms parasitize macrophages using an incompletely characterized process that evades activation of the respiratory burst (15) and impedes subsequent phagolysosomal fusion (16) . The use of antibody-coated T. gondii or activated macrophages, each of which promoted phagolysosomal fusion, was not associated with the shift in AA metabolism induced by viable organisms. Distinct macrophage pools of AA have been described, and their availability after membrane events may be stimulus dependent (5) . The ability to label compound X with macrophage-derived but not T. gondii-derived [3H]AA (Fig.  4 ) would be consistent with the concept of different AA pools. A lysosomal location of at least one phospholipase A2 has been suggested (25) ; it is possible that this enzyme would not be available to viable T. gondii during phagocytosis.
The role of the parasite-mediated shift in macrophage lipoxygenase products in establishing in vivo infection is unknown. LT mediate multiple important inflammatory mechanisms, including the attraction and localization of circulating neutrophils and monocytes. Of note, both neutrophils and blood monocytes readily kill T. gondii (9, 15, 26) but are not a prominent feature of the host inflammatory response to this infection (27) . The inability of resident macrophages to generate LT during the phagocytosis of viable T. gondii would be consistent with these in vivo observations. It is also possible that compound X might directly mediate some of the cellular or systemic host responses that occur in toxoplasmosis. Our current efforts are directed at production of sufficient amounts of this compound to determine its structure and to investigate its functional activity. Reiner 
